• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2300007 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs License Renew 2023-01-05 Xian Janssen Pharmaceutical Ltd;Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHZ2300006 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs License Renew 2023-01-05 Xian Janssen Pharmaceutical Ltd;Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHZ2300005 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs License Renew 2023-01-05 Xian Janssen Pharmaceutical Ltd;Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHZ2300004 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs License Renew 2023-01-05 Xian Janssen Pharmaceutical Ltd;Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHZ2100533 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs License Renew 2021-04-28 Xian Janssen Pharmaceutical Ltd;Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHZ2100532 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs License Renew 2021-04-28 Xian Janssen Pharmaceutical Ltd;Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHZ2100531 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs License Renew 2021-04-28 Xian Janssen Pharmaceutical Ltd;Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHZ1600013 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs License Renew 2016-02-29 Janssen Inc. Janssen Inc;Johnson & Johnson Innovative Medicine Certificate Issued 2017-01-03 view
JYHZ1600012 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs License Renew 2016-02-29 Janssen Inc. Janssen Inc;Johnson & Johnson Innovative Medicine Certificate Issued 2017-01-03 view
JYHZ1600011 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs License Renew 2016-02-29 Janssen Inc. Janssen Inc;Johnson & Johnson Innovative Medicine Certificate Issued 2017-01-03 view
JYHZ1600010 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs License Renew 2016-02-29 Janssen Inc. Janssen Inc;Johnson & Johnson Innovative Medicine Certificate Issued 2017-01-03 view
JYHZ1600009 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs License Renew 2016-02-29 Janssen Inc. Janssen Inc;Johnson & Johnson Innovative Medicine Certificate Issued 2017-01-03 view
JYHB2500076 棕榈帕利哌酮酯注射液(6M) paliperidone palmitate Injection Chemical Drugs Supplementary Application 2025-02-18 Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHB2500075 棕榈帕利哌酮酯注射液(6M) paliperidone palmitate Injection Chemical Drugs Supplementary Application 2025-02-18 Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHB2500074 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs Supplementary Application 2025-02-18 Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHB2500073 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs Supplementary Application 2025-02-18 Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHB2500072 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs Supplementary Application 2025-02-18 Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHB2500071 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs Supplementary Application 2025-02-18 Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHB2500070 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs Supplementary Application 2025-02-18 Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view
JYHB2500069 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs Supplementary Application 2025-02-18 Johnson & Johnson Innovative Medicine;Janssen-Cilag International NV view